UT-Southwestern Medical Center: FDA-Designated Orphan Drug Could Increase Radiation Efficacy in Lung Cancer
May 01, 2025
May 01, 2025
DALLAS, Texas, May 1 -- The University of Texas Southwestern Medical Center issued the following news release:
* * *
FDA-designated orphan drug could increase radiation efficacy in lung cancer
UTSW researchers find crucial metabolic pathway targeted by drug creates key vulnerability in cancer cells
An FDA-designated orphan drug that can target a key vulnerability in lung cancer shows promise in improving the efficacy of radiation treatments in . . .
* * *
FDA-designated orphan drug could increase radiation efficacy in lung cancer
UTSW researchers find crucial metabolic pathway targeted by drug creates key vulnerability in cancer cells
An FDA-designated orphan drug that can target a key vulnerability in lung cancer shows promise in improving the efficacy of radiation treatments in . . .